usa
estim
million
episod
diarrhea
occur
annual
children
younger
year
age
children
seen
physician
hospit
die
ill
worldwid
number
childhood
death
diarrhea
higher
million
per
year
knowledg
diarrheal
diseas
increas
remark
past
decad
numer
bacteri
pathogen
increas
number
viral
pathogen
demonstr
caus
diarrhea
increas
understand
pathogen
mechan
led
improv
therapi
chapter
discuss
major
viral
bacteri
agent
infecti
diarrhea
includ
epidemiolog
pathogenesi
clinic
manifest
diagnosi
therapi
diarrheal
diseas
caus
viral
agent
occur
far
frequent
similar
diseas
bacteri
origin
fact
viral
gastroenter
second
common
ill
usa
common
cold
despit
frequent
occurr
viral
enteritid
identif
specif
viru
caus
agent
rel
recent
develop
rotaviru
number
small
round
structur
virus
identifi
major
caus
nonbacteri
gastroenter
children
adult
discuss
focus
establish
pathogen
continu
brief
summari
sever
newer
viral
enteropathogen
current
statu
sever
candid
pathogen
rotaviru
first
identifi
specif
viral
pathogen
duoden
cell
children
diarrhea
bishop
associ
subsequ
studi
indic
rotaviru
respons
case
diarrheal
diseas
infant
children
singl
caus
also
signific
portion
death
caus
diarrhea
develop
develop
countri
throughout
world
rotaviru
respons
hospit
diarrhea
among
children
worldwid
genu
rotaviru
classifi
member
famili
reovirida
rna
virus
rotavirus
round
particl
nm
diamet
compos
two
separ
shell
capsid
capsid
surround
icosahedr
core
structur
turn
enclos
doubl
strand
rna
core
structur
give
viru
characterist
appear
widerim
wheel
spoke
radiat
hub
name
deriv
rota
latin
wheel
rotavirus
classifi
base
antigen
properti
variou
protein
found
capsid
strictur
protein
inner
capsid
viru
determin
rotaviru
group
virus
infect
human
classifi
group
although
rotavirus
group
b
c
occasion
associ
human
diarrheal
diseas
well
next
level
classif
subgroup
determin
antigen
differ
among
protein
least
two
subgroup
known
exist
subgroup
type
prove
import
studi
patient
experi
one
episod
rotavir
infect
patient
recurr
infect
usual
necessarili
involv
agent
differ
subgroup
suggest
subgroup
antigen
suffici
induc
product
protect
antibodi
final
rotavirus
classifi
varieti
serotyp
base
antigen
differ
glycoprotein
proteasesensit
hemagglutinin
protein
found
outer
capsid
serotyp
refer
g
type
glycoprotein
g
type
respons
infect
children
serotyp
call
p
type
repres
proteas
sensit
reassort
use
candid
rotaviru
vaccin
rotaviru
infect
appear
occur
throughout
world
temper
climat
sharp
increas
incid
case
occur
winter
month
usa
peak
rotaviru
season
begin
novemb
southwest
end
northeast
april
tropic
yearround
transmiss
occur
season
variat
area
transmiss
primarili
person
person
contact
fece
contamin
fomit
spread
water
like
respiratori
transmiss
suggest
prove
although
viru
may
affect
age
group
commonli
produc
diseas
children
month
age
children
develop
rotaviru
antibodi
age
year
help
explain
observ
decreas
incid
rotavir
infect
later
childhood
diseas
occur
adult
richard
j
noel
mitchel
b
cohen
popul
howev
even
known
produc
epidem
rotaviru
infect
occur
adult
popul
approxim
half
frequenc
seen
children
one
studi
adult
whose
children
rotaviru
like
infect
adult
without
infect
children
adult
found
rotaviru
infect
asymptomat
symptom
present
gener
mild
would
seem
indic
antibodi
acquir
earlier
life
provid
protect
benefit
age
group
appear
rel
protect
rotaviru
infect
neonat
viru
found
stool
sampl
asymptomat
neonat
neonat
epidem
rotaviru
excret
describ
approxim
half
nurseri
patient
examin
found
rotaviru
mani
infant
asymptomat
diseas
mild
symptom
breastf
infant
less
like
infect
infect
infant
appar
less
like
bottlef
counterpart
suffer
symptom
diseas
may
reflect
protect
effect
matern
antibodi
colostrum
breast
milk
nosocomi
spread
rotavir
ill
among
hospit
infant
also
document
suscept
patient
come
contact
rotaviru
incub
period
occur
onset
symptom
ill
typic
begin
sudden
onset
diarrhea
vomit
diarrhea
usual
wateri
rare
may
associ
gross
occult
blood
stool
fluid
loss
diarrhea
vomit
often
sever
enough
caus
dehydr
fever
present
patient
diarrhea
caus
rotaviru
usual
last
day
shed
viru
intestin
lumen
begin
day
infect
may
persist
long
week
comparison
characterist
rotavir
infect
enter
virus
present
tabl
addit
gastrointestin
symptom
patient
rotaviru
often
respiratori
tract
symptom
patient
hospit
acut
gastroenter
rotaviru
infect
rhiniti
abnorm
breath
sound
pharyng
erythema
palpabl
cervic
adenopathi
addit
sign
otiti
media
unlik
fever
vomit
none
manifest
associ
rotaviru
infect
help
recognit
rotavir
diseas
group
infect
nonrotaviru
organ
similar
sign
symptom
clinic
symptom
rotaviru
infect
sever
patient
underli
malnutrit
malnourish
murin
rotaviru
model
smaller
inoculum
requir
infect
less
time
requir
incub
symptom
sever
addit
rotaviru
replic
occur
liver
kidney
least
immunocompromis
host
rotaviru
invad
villu
intestin
epitheli
cell
replic
caus
cell
death
slough
histolog
manifest
blunt
intestin
villi
respons
loss
villu
cell
crypt
hypertrophi
lytic
infect
highli
differenti
absorpt
enterocyt
spare
undifferenti
crypt
cell
result
loss
absorpt
capac
unoppos
crypt
cell
secret
secretori
diarrhea
loss
brush
border
hydrolas
activ
osmot
diarrhea
anoth
possibl
mechan
rotavir
diarrhea
also
demonstr
rotaviru
nonstructur
glycoprotein
shown
mediat
agedepend
intestin
secret
mice
relev
novel
viral
enterotoxin
human
rotavir
infect
uncertain
model
includ
vasoact
inflammatori
agent
also
propos
consist
rotaviru
infect
may
increas
number
inflammatori
cell
lamina
propria
diseas
effect
appar
limit
duodenum
proxim
jejunum
sinc
studi
patient
known
rotaviru
diseas
yield
normal
gastric
rectal
biopsi
rotaviru
initi
link
acut
gastroenter
electron
microscop
evid
viral
particl
biopsi
specimen
affect
patient
techniqu
continu
use
rotaviru
detect
especi
conjunct
monoclon
polyclon
antibodi
immunoelectron
microscopi
obviou
drawback
approach
need
special
personnel
equip
consequ
varieti
immunoassay
develop
detect
group
rotaviru
antigen
stool
immunoassay
sensit
specif
rang
current
support
care
oral
intraven
rehydr
mainstay
therapi
although
novel
antisecretori
therapi
report
antivir
agent
effect
rotaviru
yet
develop
howev
probiot
therapi
shown
effect
prevent
treat
rotavir
infect
treatment
lactobacillu
gg
shown
shorten
cours
rotavir
diarrhea
least
day
addit
probiot
agent
bifidobacterium
bifidum
streptococcu
thermophilu
shown
prevent
diarrheal
diseas
shed
rotaviru
chronic
hospit
set
given
formulaf
infant
oral
administr
immunoglobulin
shown
promot
faster
recoveri
rotavir
infect
therapi
may
reserv
sever
affect
hospit
infant
infant
natur
rotaviru
infect
confer
protect
subsequ
infect
protect
increas
new
infect
reduc
sever
diarrhea
strategi
develop
effect
oral
rotaviru
vaccin
involv
use
live
attenu
strain
protect
infant
mechan
natur
infect
extens
studi
strategi
rotaviru
vaccin
jennerian
approach
use
antigen
relat
rotaviru
strain
anim
host
immunogen
induc
protect
attenu
bovin
strain
initi
tri
protect
popul
other
variabl
part
attribut
antigen
differ
circul
strain
failur
anim
strain
elicit
heterotyp
protect
studi
increas
efficaci
jennerian
approach
secondgener
polyval
reassort
vaccin
develop
contain
neutral
antigen
provid
homotyp
serotypespecif
immun
four
epidemiolog
import
group
rotaviru
serotyp
vaccin
base
attenu
human
rhesu
strain
highli
effect
prevent
infect
efficaci
prevent
dehydr
associ
sever
diarrhea
rotaviru
vaccin
rotashield
wyethayerst
st
david
pa
approv
use
usa
place
american
academi
pediatr
recommend
vaccin
schedul
vaccin
efficaci
increas
incid
intussuscept
within
week
receiv
vaccin
identifi
vaccin
advers
event
report
system
vaer
lead
voluntari
withdraw
manufactur
altern
vaccin
licens
usa
time
sever
clinic
trial
licens
countri
calicivirus
winter
vomit
diseas
thought
caus
nonbacteri
gastroenter
decad
etiolog
agent
identifi
outbreak
norwalk
ohio
outbreak
patient
diarrhea
predomin
clinic
manifest
vomit
nausea
viru
particl
visual
immun
electron
microscopi
fecal
materi
deriv
norwalk
outbreak
repres
first
definit
associ
specif
viru
norwalk
viru
acut
gastroenter
subsequ
number
similar
etiolog
agent
identifi
clone
prototyp
norwalk
viru
genom
virus
group
morpholog
divers
positivestrand
rna
virus
caus
acut
gastroenter
identifi
norwalklik
agent
organ
also
name
commun
first
isol
eg
montgomeri
counti
hawaii
snow
mountain
taunton
otofuk
sapporo
virus
base
revers
transcriptionpolymeras
chain
reaction
pcr
sequenc
structur
virus
enabl
classif
human
calcivirus
hucv
use
molecular
tool
hucv
preliminarili
classifi
four
genotyp
repres
norwalk
viru
snow
mountain
agent
sapporo
viru
hepat
e
viru
recent
nomenclatur
two
genotyp
chang
renam
norwalk
viru
noroviru
sapporo
viru
sapoviru
hucv
classif
system
may
allow
develop
assay
base
recombin
hucv
antigen
pcr
product
rather
current
cumbersom
classif
scheme
reli
human
reagent
convalesc
outbreak
sera
vari
sensit
specif
molecular
tool
alreadi
allow
identif
hucv
agent
pediatr
adult
viral
gastroenter
foodborn
outbreak
well
outbreak
nurs
home
hospit
univers
set
despit
potenti
futur
understand
contribut
individu
hucv
outbreak
nonbacteri
gastroenter
norwalk
viru
still
remain
prototyp
agent
hucv
describ
greater
detail
follow
section
epidemiolog
although
noroviru
extens
studi
usa
appar
worldwid
distribut
patient
expos
noroviru
either
natur
experiment
develop
clinic
symptom
studi
evalu
preval
antinoroviru
antibodi
among
popul
variou
age
group
initi
demonstr
group
month
year
age
antibodyposit
rate
recent
epidemiolog
studi
use
baculovirusexpress
recombin
noroviru
antigen
enzymelink
immunosorb
assay
elisa
demonstr
serolog
respons
finnish
infant
month
age
data
contradict
previou
belief
noroviru
often
caus
diseas
older
children
adult
transmiss
noroviru
often
fecalor
unlik
rotaviru
usual
involv
spread
infect
larg
popul
common
sourc
rather
direct
persontoperson
contact
one
outbreak
infect
bakeri
employe
transmit
viru
food
product
approxim
peopl
outbreak
also
relat
ingest
raw
oyster
clam
contamin
water
suppli
spread
diseas
document
closedin
popul
longterm
care
facil
cruis
ship
addit
fecalor
spread
viral
gastroenter
evid
noroviru
transmit
respiratori
rout
form
aerosol
particl
vomitu
although
previous
refer
winter
vomit
diseas
noroviru
produc
outbreak
diseas
occur
throughout
year
pathophysiolog
histolog
chang
induc
noroviru
infect
host
studi
small
bowel
biopsi
infect
volunt
volunt
remain
free
clinic
symptom
normal
biopsi
specimen
wherea
symptom
exhibit
mark
specif
chang
includ
focal
area
villou
flatten
disorgan
epitheli
cell
electron
microscopi
microvilli
shorten
dilat
endoplasm
reticulum
volunt
repeat
biopsi
week
ill
normal
histolog
present
investig
demonstr
presenc
normal
gastric
rectal
histolog
patient
affect
noroviru
typic
viral
gastroenter
clinic
manifest
diseas
produc
noroviru
includ
nausea
vomit
cramp
abdomin
pain
tabl
diarrhea
said
less
consist
featur
ill
origin
outbreak
patient
experienc
diarrhea
wherea
vomit
studi
howev
found
diarrhea
occur
children
experiment
infect
adult
volunt
becom
ill
viru
fever
occur
approxim
onethird
affect
patient
respiratori
symptom
typic
part
ill
incub
period
approxim
h
note
onset
symptom
symptom
persist
h
develop
techniqu
diagnosi
noroviru
difficult
owe
lack
method
cultur
viru
vitro
lack
appropri
anim
model
use
molecularbas
diagnost
assay
like
improv
abil
recogn
infect
better
understand
import
treatment
noroviru
support
oral
rehydr
solut
use
necessari
signific
dehydr
uncommon
need
hospit
rare
enter
adenovirus
among
recent
recogn
viral
pathogen
caus
acut
gastroenter
adenovirus
larg
group
virus
long
recogn
role
pathogenesi
respiratori
infect
keratoconjunct
serotyp
known
shed
fece
infect
patient
patient
predominantli
gastrointestin
symptom
organ
detect
electron
microscopi
stool
sampl
howev
fail
grow
standard
tissu
cultur
condit
uniqu
cell
cultur
requir
allow
differenti
nonenter
adenovirus
enter
serotyp
recogn
among
common
caus
viral
childhood
gastroenter
infect
enter
adenovirus
appar
occur
throughout
year
slight
season
variat
diseas
tend
affect
predominantli
younger
children
patient
younger
year
age
enter
adenoviru
spread
fecalor
rout
transmiss
diseas
famili
contact
unusu
diarrhea
commonli
report
symptom
enter
adenovir
infect
contrast
diarrhea
viral
enteritid
diarrhea
enter
adenoviru
typic
persist
prolong
period
sometim
long
day
virus
may
excret
fece
infect
patient
week
vomit
frequent
occur
usual
mild
much
shorter
durat
diarrhea
dehydr
seen
approxim
half
affect
patient
hospit
sometim
necessari
frequenc
associ
respiratori
symptom
enter
adenoviru
infect
unclear
diagnosi
enter
adenoviru
best
made
electron
microscopi
immunoelectron
microscopi
stool
sampl
intestin
biopsi
specimen
elisa
pcr
techniqu
also
use
success
enter
adenoviru
diagnosi
treatment
mainli
support
oral
rehydr
solut
use
case
dehydr
astroviru
similar
hucv
singlestrand
rna
viru
group
small
round
structur
virus
howev
recent
deriv
sequenc
astroviru
rna
genom
reveal
agent
suffici
differ
classifi
famili
astrovirida
astroviru
worldwid
distribut
tend
infect
mainli
children
age
group
control
studi
thailand
astroviru
infect
second
common
caus
enter
rotaviru
infect
symptomat
children
astroviru
infect
occur
children
diarrhea
compar
control
compar
find
report
daycar
center
north
america
japan
children
infect
astroviru
develop
symptom
vomit
diarrhea
abdomin
pain
fever
commonli
seen
infect
agent
symptom
typic
last
day
spread
viru
may
occur
via
fecalor
rout
persontoperson
contact
contamin
food
water
asymptomat
shed
astroviru
also
report
varieti
virus
studi
determin
role
may
play
pathogenesi
human
enter
infect
except
virus
previous
discuss
detail
insuffici
data
avail
ascertain
clinic
epidemiolog
differ
among
variou
small
round
virus
pestiviru
singlestrand
rna
viru
togaviru
famili
found
fece
children
live
american
indian
reserv
diarrhea
attribut
infecti
agent
children
experienc
mild
diarrhea
sever
respiratori
complaint
coronaviru
known
caus
upper
respiratori
ill
human
shown
caus
diarrhea
anim
role
agent
human
diarrheal
diseas
unclear
least
one
studi
found
coronaviru
commonli
children
without
diarrhea
ill
coronaviru
implic
outbreak
necrot
enterocol
torovirus
pleomorph
virus
recogn
caus
enter
ill
varieti
anim
member
group
origin
describ
bern
switzerland
breda
iowa
name
citi
seen
fece
human
diarrheal
diseas
pleomorph
structur
torovirus
electron
microscopi
inadequ
prove
etiopathogen
role
virus
diarrheal
diseas
recent
find
toroviruslik
particl
immunoassay
use
valid
antibreda
viru
antiserum
lend
addit
weight
hypothesi
agent
human
gastroenter
caus
role
human
diseas
howev
remain
unproven
similarli
picobirnaviru
known
caus
diseas
anim
isol
stool
human
diarrheal
ill
cytomegaloviru
associ
enter
coliti
except
diseas
caus
gastric
cytomegaloviru
infect
enter
coliti
seem
occur
almost
exclus
among
immunocompromis
patient
popul
cytomegaloviru
caus
viremia
carri
blood
stream
varieti
site
includ
organ
gastrointestin
tract
diagnosi
may
made
viru
detect
fece
demonstr
typic
cytomegal
inclus
cell
situ
hybrid
infect
bacteri
agent
caus
diarrhea
must
first
overcom
follow
gastrointestin
tract
defens
gastric
acid
intestin
motil
mucu
secret
normal
intestin
microflora
specif
mucos
system
immun
mechan
gastric
acid
first
barrier
encount
infect
organ
mani
studi
demonstr
bactericid
properti
gastric
juic
ph
less
patient
achlorhydria
decreas
gastric
acid
secret
gastric
ph
higher
bactericid
effect
diminish
gastric
acid
serv
decreas
number
viabl
bacteria
proceed
small
intestin
organ
surviv
gastric
acid
barrier
trap
within
mucu
layer
small
intestin
facilit
movement
intestin
peristalsi
motil
intestin
abnorm
absent
organ
readili
abl
initi
infecti
process
organ
elabor
toxic
substanc
impair
intestin
motil
increas
intestin
peristalsi
occur
enter
infect
may
attempt
host
rid
infect
organ
addit
role
conjunct
intestin
motil
mucu
also
serv
provid
nonspecif
barrier
bacteri
prolifer
mucos
colon
barrier
shown
effect
prevent
toxin
exert
effect
exfoli
mucos
cell
trap
mucou
layer
may
trap
invad
microorgan
mucu
also
contain
carbohydr
analog
surfac
receptor
may
prevent
invad
organ
bind
actual
receptor
normal
endogen
microflora
gut
serv
next
line
defens
anaerob
larg
compon
normal
flora
elabor
shortchain
fatti
acid
lactic
acid
toxic
mani
potenti
pathogen
breastf
infant
line
defens
enhanc
presenc
anaerob
lactobacilli
produc
ferment
product
act
toxin
foreign
bacteria
evid
support
import
endogen
microflora
increas
suscept
infect
one
normal
flora
reduc
antibiot
administr
seen
clostridium
difficil
infect
complex
element
hostdefens
armamentarium
involv
mucos
system
immun
system
serum
secretori
antibodi
may
exert
protect
effect
intestin
level
even
though
serum
compon
produc
outsid
gut
immun
respons
may
specif
particular
infect
agent
gener
common
group
bacteri
antigen
bacteria
develop
varieti
virul
factor
tabl
overcom
host
defens
mechan
invas
mucosa
follow
intraepitheli
cell
multipl
invas
lamina
propria
product
cytotoxin
disrupt
cell
function
via
direct
alter
mucos
surfac
product
enterotoxin
polypeptid
alter
cellular
salt
water
balanc
yet
leav
cell
morpholog
undisturb
adher
mucos
surfac
result
flatten
microvilli
disrupt
normal
cell
function
bacteri
virul
mechan
act
specif
region
intestin
enterotoxin
primarili
effect
small
bowel
affect
colon
effect
cytotoxin
direct
epitheli
cell
invas
occur
predominantli
colon
enteroadhes
mechan
appear
function
small
intestin
colon
member
speci
salmonella
current
recogn
common
caus
bacteri
diarrhea
among
children
usa
surveil
data
center
diseas
control
prevent
indic
incid
diseas
caus
bacteria
increas
infect
caus
salmonella
may
result
sever
differ
clinic
syndrom
includ
acut
gastroenter
focal
nonintestin
infect
bacteremia
asymptomat
carrier
state
enter
fever
includ
typhoid
fever
entiti
may
caus
commonli
recogn
speci
salmonella
salmonella
motil
gramneg
bacillu
famili
enterobacteriacea
identifi
select
media
ferment
lactos
three
distinct
speci
salmonella
recogn
salmonella
enteritidi
salmonella
choleraesui
salmonella
typhi
enteritidi
subdivid
approxim
serotyp
serotyp
refer
genu
serotyp
name
eg
salmonella
typhimurium
rather
formal
correct
enteritidi
serotyp
typhimurium
choleraesui
typhi
known
one
serotyp
salmonella
estim
caus
million
gastrointestin
infect
year
usa
cincinnati
children
hospit
medic
center
salmonella
commonli
isol
bacteri
enteropathogen
fig
highest
attack
rate
salmonellosi
infanc
lower
incid
symptomat
infect
patient
older
year
age
nontyphoid
salmonella
usual
spread
via
contamin
water
suppli
food
meat
fresh
produc
fowl
egg
raw
milk
frequent
implic
larg
outbreak
involv
contamin
alfalfa
sprout
ship
worldwid
eggassoci
outbreak
involv
product
mayonnais
ice
cream
cold
dessert
salmonella
multipli
profus
eaten
without
cook
addit
contamin
raw
egg
although
shell
egg
frequent
contamin
number
bacteria
infect
egg
often
near
human
infect
dose
contrast
gener
time
min
one
bacterium
becom
billion
h
gener
time
min
h
although
food
sourc
may
becom
contamin
contact
infect
food
handler
farm
anim
often
infect
pet
notabl
cat
turtl
lizard
snake
chick
may
also
harbor
salmonella
persontoperson
spread
infect
also
occur
especi
common
case
involv
infant
inocula
fewer
salmonella
probabl
suffici
caus
diseas
patient
host
defens
diminish
like
develop
clinic
manifest
diseas
demonstr
patient
reduc
level
gastric
acid
may
involv
alter
macrophag
function
defect
complement
activ
damag
bone
thrombos
overcom
host
defens
salmonella
produc
diseas
process
begin
colon
ileum
colon
organ
next
invad
enterocyt
colonocyt
prolifer
within
epitheli
cell
lamina
propria
fig
lamina
propria
salmonella
may
move
mesenter
lymph
node
eventu
system
circul
caus
bacteremia
organ
invad
enterocyt
colonocyt
enter
wateri
diarrhea
coliti
bloodi
diarrhea
may
result
incub
period
h
salmonella
usual
produc
mild
selflimit
ill
character
fever
wateri
diarrhea
blood
mucu
commonli
present
stool
bacteremia
occur
approxim
salmonella
infect
children
much
less
frequent
adult
patient
may
develop
sequela
salmonella
infect
includ
pneumonia
mening
osteomyel
even
patient
sequela
occur
excret
organ
may
persist
sever
week
patient
younger
year
age
median
time
excret
week
patient
continu
shed
organ
year
longer
studi
also
shown
higher
incid
carrier
state
among
children
salmonellosi
seen
adult
local
salmonella
organ
chronic
carrier
often
biliari
tract
frequent
associ
cholelithiasi
diagnosi
salmonella
infect
made
stool
blood
cultur
use
enrich
media
cultur
materi
freshli
pass
stool
rather
rectal
swab
increas
likelihood
recov
organ
owe
increas
risk
develop
carrier
state
antimicrobi
treatment
uncompl
case
salmonella
gastroenter
recommend
treatment
recommend
patient
high
risk
develop
dissemin
diseas
includ
immunocompromis
hematolog
diseas
patient
artifici
implant
sever
coliti
pregnant
women
treatment
also
recommend
patient
age
appear
toxic
treatment
children
younger
year
age
salmonellosi
remain
controversi
increas
risk
bacteremia
secondari
infect
age
group
antimicrobi
therapi
recommend
infant
salmonella
bacteremia
parenter
antibiot
recommend
infant
younger
month
age
stool
cultur
posit
salmonella
salmonella
sensit
wide
varieti
antibiot
includ
ampicillin
mgkg
max
g
per
dose
given
everi
h
iv
day
chloramphenicol
mgkg
max
g
per
dose
given
everi
h
intraven
oral
day
trimethoprimsulfamethoxazol
trimethoprim
mgkg
max
mg
plu
sulfamethoxazol
mgkg
max
mg
per
dose
given
everi
h
oral
day
thirdgener
cephalosporin
resist
ampicillin
increas
ceftriaxon
cefotaxim
fluoroquinolon
approv
use
children
younger
year
age
often
effect
resist
agent
demonstr
followup
stool
cultur
usual
warrant
unless
patient
employ
prepar
food
evid
cure
necessari
two
three
consecut
neg
stool
cultur
obtain
day
apart
suffici
although
uncommon
usa
typhoid
fever
caus
typhi
commonli
affect
children
develop
countri
typhi
differ
salmonella
requir
human
host
diseas
caus
also
differ
sever
typic
mild
gastroenter
caus
member
genu
typhi
infect
also
higher
casefat
rate
typhoid
fever
typic
begin
period
fever
last
approxim
week
patient
complain
headach
abdomin
pain
diarrhea
usual
manifest
typhoid
fever
mani
patient
experi
constip
hepatomegali
splenomegali
also
frequent
note
characterist
rose
spot
palpabl
erythemat
lesion
typic
adult
case
typhoid
fever
occur
far
less
frequenc
pediatr
patient
patient
may
becom
chronic
carrier
diagnosi
typhoid
fever
made
basi
posit
blood
cultur
typhi
usual
sensit
sever
antimicrobi
agent
includ
ampicillin
chloramphenicol
trimethoprimsulfamethoxazol
cefotaxim
ceftriaxon
drug
choic
base
site
infect
suscept
organ
live
oral
vaccin
attenu
strain
typhi
avail
usa
sinc
one
recommend
dose
schedul
four
dose
given
everi
day
current
effort
direct
toward
develop
attenu
strain
may
provid
success
immun
singledos
therapi
vaccin
base
vi
antigen
typhi
polysaccharid
capsul
produc
seroconvers
subject
last
year
newer
oral
vaccin
base
either
differ
attenu
strain
typhi
typhi
constitut
express
vi
antigen
current
studi
bacillari
dysenteri
ill
caus
shigella
describ
ancient
greec
osler
refer
diseas
one
four
great
epidem
diseas
world
state
tropic
destroy
live
cholera
fatal
armi
powder
shot
despit
increas
knowledg
pathogenesi
treatment
shigellosi
organ
continu
signific
caus
diarrheal
diseas
shigella
gramneg
nonmotil
nonlactosefer
aerob
bacillu
close
relat
member
genu
escherichia
organ
classifi
four
speci
group
known
shigella
dysenteria
shigella
flexneri
shigella
boydii
shigella
sonnei
group
b
c
respect
member
group
b
c
exist
numer
serotyp
one
serotyp
group
known
sonnei
commonli
recov
shigella
speci
develop
world
account
isol
usa
dysenteria
flexneri
commonli
recov
speci
shigella
develop
world
shigella
worldwid
distribut
incid
sever
shigellosi
span
equal
broad
rang
highland
mayan
indian
children
incid
shigellosi
case
per
children
per
year
third
year
life
develop
world
shigella
occur
much
less
frequent
howev
studi
shigella
second
common
pathogen
identifi
case
bacteri
diarrhea
children
age
month
year
may
also
common
bacteri
caus
outbreak
diarrhea
daycar
set
outbreak
shigellosi
also
describ
residenti
institut
cruis
ship
diseas
endem
american
indian
reserv
southwest
shigella
predominantli
spread
via
fecalor
rout
persontoperson
contact
like
method
secondari
spread
household
contact
may
occur
infect
may
spread
contamin
food
water
often
occur
area
poor
sanit
inadequ
person
hygien
patient
infect
shigella
may
experi
mild
selflimit
wateri
diarrhea
clinic
indistinguish
gastroenter
caus
varieti
agent
classic
form
shigellosi
howev
bacillari
dysenteri
ill
usual
begin
fever
malais
follow
wateri
diarrhea
cramp
abdomin
pain
second
day
ill
blood
mucu
usual
present
stool
tenesmu
becom
promin
symptom
point
approxim
affect
patient
stool
volum
decreas
scant
amount
blood
mucu
pass
pattern
bloodi
mucuscontain
stool
refer
dysenteri
bacteremia
uncommon
featur
ill
sever
complic
report
includ
seizur
children
arthriti
purul
kerat
hemolyticurem
syndrom
hu
nonsuppur
arthriti
commonli
occur
extraintestin
complic
shigellosi
patient
carri
histocompat
locu
antigen
may
predispos
develop
complic
well
develop
reiter
syndrom
associ
seizur
shigellosi
earlier
attribut
neurotox
effect
shigella
toxin
shiga
toxin
seem
like
howev
seizur
may
simpli
repres
subgroup
common
febril
seizur
direct
relat
effect
shiga
toxin
shigella
found
caus
diseas
human
higher
ape
organ
potent
organ
abl
caus
diseas
healthi
adult
patient
infect
shigella
may
excret
organismsg
fece
high
rate
excret
rel
low
number
organ
requir
produc
diseas
make
possibl
widespread
distribut
diseas
shigella
exert
patholog
effect
host
bacteria
must
first
come
contact
surfac
intestin
epitheli
cell
induc
cytoskelet
rearrang
result
phagocytosi
bacteria
secret
enzym
degrad
phagosom
membran
releas
bacteria
host
cytoplasm
intracytoplasm
bacteria
move
rapidli
associ
comet
tail
made
host
cell
actin
filament
move
bacteria
reach
cell
margin
push
long
protrus
bacteria
tip
taken
neighbor
cell
allow
infect
spread
cell
cell
fig
shiga
toxin
elabor
speci
although
greater
amount
dysenteria
speci
may
play
role
pathogenesi
shigella
infect
toxin
neurotox
enterotox
cytotox
effect
structur
compos
activ
subunit
molecular
weight
kd
surround
five
bind
b
subunit
kd
b
subunit
bind
cellspecif
receptor
taken
endocytosi
within
cell
b
subunit
cleav
away
remain
subunit
shorten
proteolysi
molecul
thought
bind
ribosom
inhibit
protein
synthesi
lead
cell
death
slough
presum
mechan
cytotox
effect
enterotox
effect
shiga
toxin
ileum
may
account
earli
wateri
diarrhea
patient
sign
symptom
coliti
diagnosi
shigellosi
consid
stool
cultur
provid
definit
mean
differenti
organ
invas
pathogen
shigella
may
cultur
stool
specimen
rectal
swab
especi
mucopu
present
may
delay
sever
day
onset
symptom
recoveri
organ
sigmoidoscopi
colonoscopi
typic
reveal
friabl
mucosa
possibl
discret
ulcer
rectal
biopsi
may
use
differenti
shigellosi
ulcer
coliti
addit
rehydr
antimicrobi
therapi
recommend
shigella
shorten
cours
diseas
decreas
period
excret
organ
decreas
secondari
attack
rate
sinc
human
provid
reservoir
organ
howev
handwash
rather
use
antimicrobi
effect
method
prevent
persontoperson
spread
clinician
advis
routin
treatment
shigellosi
antibiot
argu
diseas
often
selflimit
use
antibiot
may
facilit
develop
resist
strain
may
increas
likelihood
develop
hu
sequela
recommend
antibiot
therapi
patient
sever
ill
time
diagnosi
remain
ill
time
identif
shigella
stool
cultur
wide
rang
antibiot
use
treat
shigella
necessit
develop
resist
strain
current
agent
choic
trimethoprimsulfamethoxazol
trimethoprim
mgkg
max
mg
plu
sulfamethoxazol
mgkg
max
mg
per
dose
given
everi
h
oral
intraven
day
ampicillin
mgkg
max
mg
per
dose
given
everi
h
oral
iv
day
may
use
local
strain
typic
suscept
amoxicillin
ineffect
shigella
nalidix
acid
mgkg
per
day
given
everi
h
day
also
prove
effect
cefixim
ceftriaxon
altern
agent
resist
organ
tetracyclin
ciprofloxacin
norfloxacin
use
success
treatment
shigella
agent
approv
use
adult
patient
multidrugresist
strain
occur
latin
america
central
africa
southeast
asia
develop
vaccin
shigellosi
current
pursu
effort
includ
vaccin
use
modifi
escherichia
coli
strain
one
use
mutant
strain
flexneri
lack
abil
prolifer
intracellularli
one
base
strain
mutat
virul
gene
campylobact
gramneg
motil
curv
spiralshap
rod
exhibit
seagul
appear
identifi
stain
stool
smear
multipl
speci
campylobact
recogn
includ
campylobact
jejuni
campylobact
fetu
campylobact
coli
campylobact
laridi
c
jejuni
one
commonli
associ
diseas
human
campylobact
upsaliensi
report
anoth
member
group
caus
diarrhea
seem
probabl
still
other
may
identifi
campylobact
recogn
worldwid
distribut
develop
countri
campylobact
signific
bacteri
caus
diarrhea
children
younger
year
age
yet
rare
occur
develop
nation
older
children
adult
infect
occur
popul
older
year
age
tend
asymptomat
like
patient
countri
infect
campylobact
earli
life
develop
immun
thu
make
asymptomat
infect
typic
older
children
adult
industri
world
patient
infect
campylobact
develop
symptom
number
campylobact
infect
countri
recogn
quit
high
studi
find
organ
common
caus
bacteri
diarrhea
campylobact
tend
infect
peopl
two
distinct
age
group
children
first
year
life
young
adult
campylobact
may
spread
direct
contact
contamin
sourc
food
water
milk
meat
egg
especi
undercook
implic
outbreak
sourc
may
contamin
human
fecal
shed
organ
may
harbor
asymptomat
farm
anim
campylobact
commonli
spread
among
popul
children
daycar
center
mechan
campylobact
produc
diseas
fulli
understood
like
involv
three
potenti
mechan
adher
intestin
mucosa
follow
elabor
toxin
invas
mucosa
termin
ileum
colon
transloc
organ
penetr
mucosa
replic
lamina
propria
mesenter
lymph
node
varieti
pathogen
mechan
may
account
spectrum
diseas
caus
campylobact
also
conceiv
differ
strain
serotyp
campylobact
may
demonstr
differ
pathogen
mechan
seen
e
coli
campylobact
may
caus
diseas
rang
mild
diarrhea
frank
dysenteri
typic
patient
experi
fever
malais
follow
diarrhea
nausea
abdomin
pain
may
mimic
append
inflammatori
bowel
diseas
symptom
usual
resolv
less
week
bacteremia
may
rare
occur
speci
implic
often
other
campylobact
also
known
caus
mening
abscess
septic
abort
pancreat
pneumonia
syndrom
reiter
syndrom
document
occur
sequela
campylobact
infect
increas
evid
implic
c
jejuni
common
anteced
syndrom
variant
form
millerfish
syndrom
neuropathi
associ
ataxia
areflexia
ophthalmoplegia
although
evid
molecular
mimicri
still
preliminari
like
peripher
nerv
share
epitop
c
jejuni
therefor
immun
respons
initi
mount
attack
c
jejuni
misdirect
peripher
nerv
resolut
symptom
patient
may
continu
shed
organ
long
week
cultur
organ
gold
standard
diagnosi
routin
accomplish
laboratori
select
media
use
cultur
incub
diseas
caus
campylobact
usual
mild
selflimit
support
treatment
alon
suffic
case
sever
diseas
erythromycin
mgkg
max
mg
per
dose
given
everi
h
day
recommend
need
antibiot
therapi
question
base
part
sever
studi
demonstr
decreas
durat
excret
campylobact
antibiot
treatment
decreas
durat
symptom
gener
studi
antimicrobi
therapi
begun
late
cours
ill
placebocontrol
doubleblind
trial
salazarlindo
colleagu
demonstr
shorten
durat
ill
day
patient
receiv
erythromycin
day
ill
case
campylobact
septicemia
gentamicin
mgkg
per
dose
im
iv
given
everi
h
recommend
chloramphenicol
erythromycin
accept
altern
tetracyclin
mg
per
dose
iv
given
everi
h
may
use
patient
older
year
age
ciprofloxacin
effect
altern
agent
approv
use
children
younger
year
age
antibiot
treatment
recommend
outbreak
campylobact
daycar
set
treatment
shown
elimin
fecal
shed
organ
within
h
genu
yersinia
includ
speci
yersinia
pesti
caus
plagu
yersinia
pseudotuberculosi
known
caus
pseudoappend
mesenter
aden
gastroenter
yersinia
enterocolitica
recogn
increas
frequenc
caus
bacteri
diarrhea
yersinia
gramneg
coccoid
bacillu
facult
anaerob
nonlactosefer
observ
motil
temperatur
nonmotil
yersinia
initi
thought
occur
greater
frequenc
countri
cooler
climat
recogn
worldwid
distribut
although
true
incid
preval
organ
known
area
yersiniosi
occur
frequent
shigellosi
outbreak
due
yersinia
associ
spread
contamin
water
food
includ
bean
sprout
tofu
chocol
milk
pork
also
implic
sourc
fulton
counti
georgia
outbreak
chitterl
found
vehicl
infect
organ
tend
caus
diseas
frequent
young
children
month
median
age
one
studi
yersinia
may
also
spread
among
household
contact
addit
may
increas
incid
summer
month
pathogenesi
enterocolitica
constitut
heterogen
group
serotyp
mani
identifi
virul
factor
enterocolitica
produc
diseas
intestin
invas
rout
penetr
mucos
epithelium
primarili
ileum
organ
replic
peyer
patch
accumul
mesenter
lymph
node
serotyp
produc
enterotoxin
similar
e
coli
heatstabl
toxin
temperatur
lower
therefor
toxin
may
import
role
diseas
product
yersinia
human
intestin
specul
role
preform
toxin
caus
diseas
toxin
may
produc
organ
present
refriger
food
virul
enterocolitica
shown
plasmid
relat
differ
serotyp
exhibit
differ
degre
virul
serotyp
one
frequent
associ
diarrheal
diseas
europ
japan
wherea
larger
number
serotyp
seen
north
america
frequent
clinic
syndrom
caus
enterocolitica
gastroenter
typic
affect
young
children
incub
period
day
patient
develop
diarrhea
fever
abdomin
pain
mark
increas
leukocyt
count
common
symptom
usual
resolv
day
known
persist
sever
month
excret
organ
occur
week
sever
complic
includ
append
document
enterocolitica
infect
howev
older
children
young
adult
yersinia
like
produc
pseudoappendicular
syndrom
sign
symptom
mimic
append
age
group
also
associ
enterocolitica
nonspecif
abdomin
pain
radiograph
chang
termin
ileum
often
associ
crohn
diseas
name
mucos
thicken
aphthou
ulcer
seen
yersiniosi
young
adult
yersinia
bacteremia
occur
despit
therapi
appropri
antibiot
casefat
rate
find
yersinia
blood
asymptomat
donor
howev
make
possibl
transient
bacteremia
seem
like
well
sequela
yersinia
infect
includ
erythema
nodosum
reactiv
arthropathi
howev
commonli
seen
adult
arthropathi
tend
involv
weightbear
joint
lower
extrem
note
occur
often
yersinia
patient
carri
histocompat
antigen
yersinia
may
cultur
use
select
media
prefer
cold
enrich
despit
best
method
cultur
yersinia
may
requir
long
week
addit
diagnosi
cultur
yersinia
may
also
detect
serolog
use
agglutinin
titer
measur
appear
use
conjunct
cultur
agglutinin
titer
may
affect
number
factor
includ
patient
age
underli
diseas
previou
use
antibiot
immunosuppress
agent
titer
may
also
use
europ
japan
infect
caus
restrict
number
serotyp
antibiot
proven
effect
allevi
symptom
yersinia
shorten
period
excret
pai
associ
compar
efficaci
trimethoprimsulfamethoxazol
vs
placebo
treatment
yersinia
gastroenter
found
signific
differ
note
howev
therapi
begun
near
end
cours
ill
case
sever
diseas
patient
underli
ill
treatment
recommend
trimethoprimsulfamethoxazol
aminoglycosid
chloramphenicol
thirdgener
cephalosporin
gener
recommend
tetracyclin
quinolon
altern
choic
adult
patient
gentamicin
chloramphenicol
recommend
treatment
septicemia
septicemia
may
associ
iron
overload
state
cessat
iron
therapi
also
recommend
infect
although
cholera
diseas
rare
encount
develop
countri
remain
import
entiti
investig
pathogenesi
cholera
led
recognit
understand
mechan
action
cholera
toxin
remain
prototyp
bacteri
enterotoxin
cholera
also
import
therapeut
perspect
initi
effort
use
oral
rehydr
solut
carri
patient
cholera
howev
importantli
worldwid
basi
cholera
continu
major
public
health
problem
almost
develop
countri
cholera
afflict
children
adult
cholera
exist
endem
diseas
countri
world
death
rate
highli
depend
treatment
facil
highest
mortal
rate
africa
casefat
rate
approxim
especi
epidem
attack
like
cholera
endem
infect
caus
death
annual
vibrio
cholera
gramneg
motil
curv
bacillu
freeliv
bodi
salt
water
v
cholera
classifi
basi
lipopolysaccharid
antigen
recent
epidem
strain
v
cholera
serotyp
group
subdivid
two
biotyp
classic
el
tor
serotyp
thought
caus
sporad
case
diarrhea
epidem
diseas
dictum
discard
develop
ongo
epidem
asia
south
america
caus
new
serotyp
synonym
bengal
although
pathogenesi
clinic
featur
cholera
ident
cholera
person
immun
serotyp
immun
bengal
serotyp
lack
immun
primarili
result
uniqu
cell
surfac
antigen
v
cholera
spread
via
contamin
food
water
suppli
evid
anim
reservoir
human
may
serv
transient
carrier
rare
occas
human
may
chronic
carri
organ
owe
natur
spread
person
live
area
adequ
sanit
minim
risk
encount
cholera
cholera
occur
usa
usual
result
import
food
brought
back
return
intern
travel
travel
usa
endem
area
low
risk
per
travel
cholera
also
isol
oyster
gulf
coast
howev
owe
frequenc
intern
travel
import
clinician
encount
patient
sever
cholera
symptom
dehydr
ricewat
stool
suspect
infect
even
nonendem
area
v
cholera
enter
potenti
host
oral
rout
usual
contamin
food
water
volunt
studi
shown
rel
larg
number
organ
approxim
must
ingest
produc
symptom
similar
ingest
organ
v
cholera
must
surviv
acid
gastric
environ
import
gastric
acid
hostprotect
factor
born
increas
occurr
cholera
patient
absent
reduc
gastric
acid
organ
travel
small
intestin
adher
epithelium
process
may
aid
product
mucinas
intestin
epithelium
remain
intact
normal
morpholog
vibrio
speci
produc
toxin
compos
central
subunit
surround
five
b
subunit
latter
bind
gangliosid
gm
serv
toxin
receptor
bind
facilit
transfer
subunit
across
cell
membran
cleav
two
compon
denot
disulfid
linkag
reduc
liber
activ
peptid
act
catalyst
facilit
transfer
adenosin
diphosphateribos
nicotinamid
adenin
dinucleotid
guanyl
nucleotidebind
regulatori
protein
g
g
stimul
adenyl
cyclas
locat
basolater
membran
therebi
increas
cyclic
adenosin
monophosph
result
turn
lead
chlorid
secret
net
flux
fluid
intestin
lumen
although
mechan
toxin
action
adequ
explain
clinic
symptom
cholera
similar
symptom
note
patient
infect
strain
produc
classic
cholera
toxin
led
recognit
v
cholera
harbor
addit
virul
factor
bacteri
genom
may
contribut
diarrheal
diseas
must
consid
design
nonreactigen
vaccin
newli
recogn
toxin
produc
v
cholera
includ
zonula
occluden
toxin
accessori
cholera
toxin
incub
period
commonli
day
symptom
cholera
usual
begin
abruptli
vomit
profus
wateri
diarrhea
stool
soon
becom
clear
bit
mucu
give
socal
ricewat
appear
patient
experi
tenesmu
rather
sens
relief
defec
typic
fever
rate
fluid
loss
cholera
remark
sever
diseas
purg
rate
excess
lh
report
adult
patient
despit
dramat
present
health
risk
cholera
gravi
patient
cholera
infect
asymptomat
experi
mild
symptom
addit
peopl
reduc
gastric
acid
peopl
blood
group
increas
risk
sever
diseas
host
factor
predispos
increas
purg
less
clear
v
cholera
identifi
coloni
morpholog
pigment
select
agar
eg
thiosulf
citrat
bile
saltsucros
agar
identif
depend
biochem
marker
eg
posit
oxidas
reaction
motil
organ
specif
serotyp
use
confirm
identif
mainstay
cholera
treatment
rehydr
case
diseas
less
sever
recogn
earli
oral
rehydr
solut
appropri
effect
purg
excess
mlkg
per
h
intraven
rehydr
requir
antibiot
shown
caus
decreas
durat
diarrhea
total
amount
fluid
lost
length
time
organ
excret
tetracyclin
mg
per
dose
given
everi
h
day
recommend
appropri
antibiot
adult
furazolidon
mgkg
max
mg
per
dose
given
everi
h
day
suggest
children
pregnant
patient
ampicillin
chloramphenicol
trimethoprimsulfamethoxazol
doxycyclin
may
also
use
singledos
ciprofloxacin
also
shown
effect
treatment
v
cholera
although
drug
approv
use
children
despit
much
progress
ideal
cholera
vaccin
yet
avail
ideal
vaccin
would
provid
high
level
longterm
protect
even
high
risk
sever
ill
eg
peopl
blood
group
type
protect
would
commenc
shortli
administr
singl
oral
dose
new
oral
vaccin
develop
cholera
includ
kill
vaccin
live
attenu
strain
cvd
vaccin
strain
delet
ctxa
prove
efficaci
experiment
challeng
v
cholera
el
tor
inaba
month
inocul
suggest
may
use
travel
endem
area
unfortun
cvd
effect
field
trial
nonmotil
strain
colon
better
cvd
shown
highli
effect
volunt
studi
despit
success
remain
need
continu
develop
nonreactigen
vaccin
vaccin
new
epidem
strain
neither
kill
live
vaccin
protect
new
serotyp
sinc
protect
lipopolysaccharidemedi
new
serotyp
uniqu
lipopolysaccharid
therefor
appear
new
serotyp
reinforc
need
test
addit
vaccin
candid
noncholera
vibrio
v
parahaemolyticu
v
fluviali
v
mimicu
v
hollisa
v
furnissii
v
vulnifican
shown
caus
gastrointestin
ill
wound
infect
septicemia
although
organ
characterist
noncholera
vibrio
produc
protein
toxin
ident
classic
cholera
toxin
speci
also
produc
heatstabl
toxin
similar
e
coli
heatstabl
toxin
although
organ
produc
choleralik
ill
stool
may
sometim
contain
blood
leukocyt
sepsi
occur
led
specul
member
group
name
v
parahaemolyticu
may
capabl
invas
well
toxin
product
usa
gastroenter
caus
vibrio
often
associ
ingest
raw
oyster
gastroenter
caus
vibrio
tend
far
milder
caus
v
cholera
sever
case
diarrhea
septicemia
antibiot
may
help
agent
use
v
cholera
recommend
e
coli
constitut
divers
group
organ
includ
nonpathogen
strain
among
common
bacteria
normal
flora
human
intestin
pathogen
strain
pathogen
e
coli
strain
caus
diarrheal
ill
recogn
sinc
diarrheagen
e
coli
studi
extens
current
classifi
basi
serogroup
pathogen
mechan
six
major
group
enteropathogen
e
coli
epec
import
caus
diarrhea
infant
develop
countri
enterotoxigen
e
coli
etec
caus
diarrhea
infant
develop
area
world
caus
travel
diarrhea
adult
enteroinvas
e
coli
eiec
caus
either
wateri
eteclik
ill
less
commonli
dysenterylik
ill
shiga
toxinproduc
e
coli
stxproduc
formerli
known
enterohemorrhag
e
coli
caus
hemorrhag
coliti
hu
enteroaggreg
e
coli
eaggec
diffuselyadher
e
coli
daec
along
epec
implic
caus
persist
diarrhea
group
e
coli
uniqu
properti
tabl
epec
major
caus
diarrhea
develop
countri
mani
case
infant
diarrhea
particularli
infant
less
age
may
caus
epec
studi
frequenc
epec
infect
exce
rotaviru
north
america
uk
epec
infect
common
commonli
associ
sporad
case
nosocomi
daycar
outbreak
howev
gener
unavail
serotyp
true
incid
epecassoci
diarrhea
may
underestim
studi
seattl
children
diarrhea
dna
probe
use
screen
e
coli
present
stool
found
high
incid
epeclik
organ
atyp
epec
popul
hallmark
epec
infect
attach
effac
lesion
seen
intestin
adher
bacterium
epitheli
cell
membran
directli
beneath
surfac
adher
organ
mark
cytoskelet
chang
enterocyt
includ
accumul
actin
polym
often
bacteria
rais
pedestallik
structur
result
actin
accumul
number
step
probabl
respons
develop
attach
effac
lesion
propos
donnenberg
kaper
epec
pathogenesi
consist
three
phase
local
adher
bring
bacteria
close
contact
enterocyt
eg
dock
signal
transduct
includ
increas
intracellular
calcium
protein
phosphoryl
intim
adher
multigen
process
encod
bacterium
locu
enterocyt
effac
dramat
loss
absorpt
microvilli
intestin
presum
lead
diarrhea
via
malabsorpt
although
probabl
predomin
mechan
evid
suggest
separ
secretori
mechan
also
involv
patient
symptomat
epec
infect
typic
experi
diarrhea
vomit
malais
fever
stool
may
contain
mucu
usual
contain
blood
symptom
epec
infect
sever
enter
infect
may
persist
week
longer
patient
epec
caus
protract
diarrhea
dehydr
malnutrit
zinc
defici
complic
treatment
parenter
hyperaliment
requir
epec
detect
serotyp
isol
e
coli
demonstr
presenc
enterocyt
adher
factor
virul
gene
use
molecular
probe
identif
attach
effac
phenotyp
use
tissu
cultur
cell
assay
commonli
use
clinic
microbiolog
laboratori
diagnosi
epec
may
made
demonstr
presenc
adher
organ
small
intestin
rectal
biopsi
although
control
studi
antibiot
therapi
epec
signific
morbid
associ
agent
argu
treatment
antibiot
case
trimethoprimsulfamethoxazol
trimethoprim
mgkg
max
mg
plu
sulfamethoxazol
mgkg
max
mg
per
dose
given
everi
h
use
success
oral
neomycin
gentamicin
etec
recogn
import
caus
diarrhea
infant
develop
area
world
endem
area
children
first
year
life
may
infect
sever
time
year
usa
case
etec
among
children
uncommon
etec
also
major
caus
travel
diarrhea
adult
fecalor
transmiss
consumpt
heavili
contamin
food
water
common
vehicl
etec
infect
product
diseas
etec
begin
colon
small
intestin
bacteria
depend
fimbria
also
call
pili
facilit
attach
mucos
surfac
overcom
forward
motion
peristalsi
attach
process
caus
detect
structur
chang
architectur
brush
border
membran
allow
bacteria
releas
enterotoxin
heatlabil
toxin
lt
heatstabl
toxin
st
close
proxim
enterocyt
brush
border
membran
toxin
receptor
present
toxin
turn
stimul
adenyl
cyclas
case
lt
guanyl
cyclas
case
st
ultim
result
net
fluid
secret
intestin
see
review
cohen
giannella
sear
kaper
two
endogen
ligand
st
receptor
guanylin
uroguanylin
identifi
discoveri
consist
hypothesi
st
superagonist
exert
diarrheal
action
mean
usurp
normal
secretori
mechan
intestin
eg
molecular
mimicri
less
potent
endogen
ligand
uroguanylin
may
also
act
hormon
regul
salt
water
excret
kidney
respons
oral
salt
load
clinic
etec
infect
caus
nausea
abdomin
pain
wateri
diarrhea
stool
typic
contain
neither
mucu
leukocyt
etec
diagnos
use
bioassay
suckl
mous
assay
immunoassay
gene
probe
specif
either
st
lt
pcr
assay
also
avail
howev
none
assay
commonli
use
clinic
microbiolog
laboratori
support
measur
suffici
therapi
case
etec
diarrhea
oral
rehydr
mainstay
therapi
antibiot
includ
trimethoprimsulfamethoxazol
shown
decreas
durat
fecal
excret
organ
quinolon
antibiot
may
effect
recommend
use
children
eiec
share
mani
common
featur
includ
virul
mechan
shigella
organ
preferenti
colon
colon
invad
replic
within
epitheli
cell
caus
cell
death
addit
organ
elabor
one
secretori
enterotoxin
clinic
shigella
eiec
infect
character
period
wateri
diarrhea
preced
onset
dysenteri
scanti
stool
contain
mucu
pu
blood
commonli
contrast
shigella
first
phase
wateri
diarrhea
seen
eiec
infect
ill
clinic
indistinguish
caus
bacteri
diarrhea
eg
etec
nonbacteri
infecti
diarrhea
minor
patient
eiec
infect
dysenteri
syndrom
characterist
stool
tenesmu
fever
also
seen
bacteremia
report
infect
due
eiec
uncommon
foodborn
outbreak
diseas
occur
usa
aboard
cruis
ship
diagnosi
depend
bioassay
sereni
test
serotyp
elisa
dna
probe
techniqu
none
test
commonli
avail
clinic
laboratori
treatment
current
limit
support
measur
although
ampicillin
given
intramuscularli
associ
bacteriolog
cure
clinic
improv
stxproduc
e
coli
distinct
class
organ
identifi
sinc
caus
two
recogniz
syndrom
hemorrhag
coliti
hu
hemorrhag
coliti
ill
character
crampi
abdomin
pain
initi
wateri
diarrhea
subsequ
develop
grossli
bloodi
diarrhea
littl
fever
although
may
serotyp
class
diarrheagen
e
coli
north
america
e
coli
serotyp
prototyp
member
famili
organ
e
coli
common
caus
infecti
bloodi
diarrhea
usa
similarli
hu
defin
triad
acut
renal
failur
thrombocytopenia
microangiopath
hemolyt
anemia
also
highli
associ
anteced
e
coli
infect
stxproduc
e
coli
infect
may
occur
sporad
case
also
associ
outbreak
diseas
nurs
home
daycar
center
institut
sever
review
publish
estim
e
coli
caus
approxim
infect
per
year
usa
alon
may
respons
death
annual
inadequ
cook
hamburg
like
sourc
first
outbreak
remain
common
vehicl
transmiss
larg
epidem
western
usa
inadequ
cook
hamburg
implic
caus
small
epidem
attribut
appl
juic
cider
largescal
outbreak
japan
associ
bean
sprout
contamin
water
also
sourc
infect
common
outbreak
reservoir
stxproduc
e
coli
intestin
cattl
anim
asymptomat
infect
spread
either
direct
contact
intestin
content
drop
water
runoff
contamin
pastur
low
infecti
dose
stxproduc
e
coli
resist
organ
gastric
acid
food
preserv
process
high
salt
dri
contribut
high
attack
rate
low
infecti
dose
also
contribut
frequent
persontoperson
transmiss
old
young
appear
increas
risk
stxproduc
e
coli
infect
complic
clinic
featur
complic
e
coli
infect
includ
bloodi
diarrhea
nonbloodi
diarrhea
hu
thrombot
thrombocytopen
purpura
uncommonli
asymptomat
infect
symptom
may
persist
sever
day
less
commonli
sever
week
earli
report
suggest
carriag
organ
brief
prompt
cultur
necessari
recov
organ
recent
prolong
shed
observ
led
recommend
two
neg
stool
cultur
obtain
child
allow
return
daycar
identif
stxproduc
e
coli
made
difficult
possibl
differenti
diseaseproduc
e
coli
normal
enter
flora
basi
standard
microbiolog
techniqu
current
six
techniqu
identif
stxproduc
e
coli
biochem
marker
serotyp
commonli
use
serum
antibodi
test
cytotoxin
bioassay
dna
hybrid
pcrbase
test
cytotoxin
detect
includ
elisa
method
eg
toxinbas
assay
detect
presenc
cytotoxinproduc
organ
includ
serotyp
may
import
use
biochem
marker
toxinbas
assay
clinic
practic
identifi
organ
prevent
diseas
transmiss
made
difficult
fact
organ
colon
intestin
healthi
cattl
food
anim
includ
beef
pork
lamb
poultri
therefor
surviv
multipli
food
chain
proper
cook
destroy
organ
hamburg
intern
cook
temperatur
render
meat
safe
practic
safe
cook
commonli
result
gray
hamburg
pink
clear
juic
risk
lower
educ
consum
crosscontamin
use
warn
label
affix
meat
usa
improv
meat
process
microbi
contamin
detect
present
effect
therapi
treat
stxproduc
e
coli
diseas
prevent
import
strategi
hemorrhag
coliti
confus
number
condit
includ
ischem
coliti
append
crohn
diseas
ulcer
coliti
cecal
polyp
pseudomembran
coliti
acut
abdomen
ileiti
therefor
import
aspect
treatment
stxassoci
hemorrhag
coliti
make
correct
diagnosi
avoid
unnecessari
diagnost
studi
angiographi
laparotomi
mainstay
therapi
hemorrhag
coliti
manag
dehydr
electrolyt
abnorm
gastrointestin
blood
loss
antimicrobi
agent
may
help
kill
bacteri
pathogen
may
also
caus
harm
increas
releas
subsequ
absorpt
shiga
toxin
trial
antibiot
treatment
stxproduc
e
coli
infect
inconclus
although
organ
uniformli
sensit
antimicrobi
vitro
present
convinc
evid
antimicrobi
therapi
help
diminish
sever
ill
shorten
durat
fecal
excret
prevent
hu
greater
concern
studi
suggest
increas
incid
hu
treat
antimicrobi
attempt
assimil
find
publish
seri
subject
via
metaanalysi
fail
identifi
increas
risk
hu
treat
antimicrobi
regardless
data
avail
topic
expert
would
agre
treatment
stxproduc
e
coli
antimicrobi
advis
multicent
trial
fail
demonstr
improv
clinic
cours
pediatr
patient
treat
shiga
toxinbind
resin
toxin
neutral
therapi
current
investig
eaggec
daec
initi
categor
part
larger
group
enteroadher
e
coli
strain
differ
classic
epec
strain
showloc
adher
cell
assay
aggreg
stack
brick
appear
eaggec
bioassay
permit
epidemiolog
investig
eaggec
found
associ
persist
diarrhea
develop
counti
uncertainti
eaggec
pathogen
organ
found
appar
healthi
individu
epidemiolog
studi
fail
show
associ
diseas
howev
evid
volunt
studi
outbreak
confirm
pathogen
eaggec
strain
recent
studi
cincinnati
children
hospit
medic
center
shown
eaggec
import
unrecogn
caus
acut
infant
diarrhea
mechan
organ
caus
diseas
thought
involv
adher
intestin
mucosa
possibl
small
larg
intestin
follow
secret
one
enterotoxin
andor
stimul
releas
flagellar
protein
daec
less
well
character
also
associ
diarrheal
diseas
cell
assay
dna
probe
use
identifi
organ
routin
avail
clinic
microbiolog
laboratori
c
difficil
gramposit
anaerob
bacillu
diseas
caus
organ
manifest
varieti
way
rang
asymptomat
carriag
potenti
lifethreaten
pseudomembran
coliti
organ
primarili
exclus
associ
ill
occur
disrupt
normal
intestin
flora
antibiot
great
interest
studi
c
difficil
differ
incid
isol
organ
toxin
variou
age
group
c
difficil
toxin
found
fece
normalterm
neonat
neonat
intens
care
unit
infant
found
toxin
stool
asymptomat
small
group
toxinposit
infant
sign
symptom
necrot
enterocol
clear
relat
c
difficil
toxin
demonstr
presenc
c
difficil
toxin
asymptomat
infant
may
indic
coexist
protect
antitox
substanc
may
reflect
lack
appropri
toxin
receptor
patient
age
group
incid
c
difficil
toxin
posit
decreas
beyond
neonat
period
incid
asymptomat
carriag
children
older
year
age
approach
healthi
adult
furthermor
organ
toxin
produc
adult
develop
diseas
c
difficil
infect
also
like
children
experi
sever
coliti
symptom
c
difficil
elabor
two
import
toxin
toxin
probabl
mediat
human
diseas
call
enterotoxin
despit
fact
caus
cytotox
hemorrhag
mucos
destruct
addit
enterotox
effect
toxin
larg
protein
kd
bind
enterocyt
surfac
receptor
activ
intracellular
g
proteindepend
signal
transduct
mechan
bound
toxin
result
alter
permeabl
inhibit
protein
synthesi
direct
cytotox
toxin
b
thought
import
mediat
human
diseas
howev
cytotoxin
almost
alway
found
toxin
toxin
b
basi
gold
standard
cytotox
tissu
cultur
assay
c
difficilerel
diarrhea
almost
alway
occur
set
antimicrobi
administr
less
commonli
syndrom
pseudomembran
enterocol
seen
surgeri
without
antimicrobi
agent
antineoplast
therapi
mucos
diseas
includ
inflammatori
bowel
diseas
thought
risk
factor
pediatr
patient
inflammatori
bowel
diseas
found
c
difficil
toxin
stool
good
control
hospit
major
risk
factor
acquisit
infect
patient
experi
mild
wateri
diarrhea
last
day
spontan
resolv
patient
symptom
persist
week
month
pseudomembran
coliti
develop
subset
patient
patient
diseas
often
extrem
ill
high
fever
leukocytosi
hypoalbuminemia
c
difficil
suspect
case
coliti
mild
diarrhea
blood
leukocyt
note
stool
concurr
recent
exposur
within
sever
week
antibiot
increas
suspicion
c
difficil
caus
agent
use
virtual
antibiot
may
predispos
c
difficil
diseas
diagnosi
c
difficil
made
cultur
organ
examin
presenc
toxin
fece
gold
standard
laboratori
detect
c
difficil
toxin
requir
use
tissu
cultur
system
demonstr
cytopath
effect
neutral
specif
antitoxin
howev
less
commonli
use
assay
includ
rapid
toxin
elisa
assay
sensit
specif
approach
tissu
cultur
system
interpret
within
hour
howev
correct
identif
c
difficil
diseas
children
may
requir
use
toxin
toxin
b
elisa
sigmoidoscopi
case
pseudomembran
coliti
typic
reveal
friabl
white
exud
overli
multipl
ulcer
area
histolog
find
lesion
depict
figur
less
commonli
pseudomembran
may
present
rectosigmoid
may
present
proxim
colon
case
mild
diarrheal
ill
caus
c
difficil
discontinu
antibiot
patient
receiv
may
suffici
therapi
case
sever
ill
especi
case
pseudomembran
coliti
treatment
also
includ
oral
vancomycin
mgkg
max
mg
per
dose
given
everi
h
day
metronidazol
mgkg
max
mg
per
dose
given
everi
h
day
compar
vancomycin
metronidazol
much
less
expens
select
vancomycinresist
organ
similar
efficaci
fairli
high
rate
relaps
ill
gener
treatment
c
difficil
relaps
usual
occur
within
month
complet
therapi
thought
result
activ
c
difficil
spore
remain
primari
infect
case
relaps
respons
second
cours
vancomycin
metronidazol
repeat
short
cours
drug
report
multipl
relaps
cholestyramin
given
slurri
mgkg
per
dose
everi
h
week
taper
follow
week
effect
erad
organ
intraven
administ
gamma
globulin
altern
therapi
chronic
c
difficil
enterocol
lactobacillu
gg
also
use
success
pediatr
patient
recurr
persist
infect
saccharomyc
boulardii
use
effect
adult
within
past
decad
sever
organ
previous
recogn
enter
pathogen
link
diarrheal
diseas
includ
organ
genu
aeromona
close
relat
bacterium
plesiomona
shigelloid
previous
classifi
aeromona
shigelloid
organ
gramneg
facult
anaerob
bacilli
classifi
famili
vibrionacea
oxidaseposit
differenti
member
enterobacteriacea
sever
member
genu
aeromona
includ
aeromona
hydrophila
common
inhabit
fresh
brackish
water
usa
organ
initi
recogn
opportunist
pathogen
immunocompromis
host
especi
malign
hematolog
diseas
organ
also
known
caus
diseas
patient
underli
hepatobiliari
diseas
aeromona
isol
healthi
person
well
therefor
thought
part
normal
flora
despit
initi
studi
yield
conflict
result
gener
accept
hydrophila
enter
pathogen
studi
australian
children
diarrhea
found
aeromona
speci
present
patient
infect
appear
occur
frequent
children
younger
year
age
patient
aeromona
isol
stool
cultur
cincinnati
children
hospit
medic
center
approxim
younger
month
aeromona
infect
also
season
occur
often
summer
month
aeromona
speci
pathogen
method
pathogenesi
remain
unclear
cytotox
enterotox
properti
observ
neither
pathogen
mechan
found
consist
strain
isol
patient
aeromonasassoci
diseas
aeromona
cavia
commonli
isol
speci
demonstr
adher
cytotoxin
product
clinic
symptom
attribut
aeromona
group
three
categori
acut
wateri
diarrhea
common
syndrom
dysenteri
usual
selflimit
persist
wateri
diarrhea
cramp
abdomin
pain
vomit
may
also
occur
symptom
may
occasion
sever
especi
dysenteri
present
incorrectli
diagnos
ulcer
coliti
mild
case
aeromona
infect
support
treatment
suffic
patient
immunocompromis
otherwis
acut
ill
persist
ill
treatment
antibiot
recommend
trimethoprimsulfamethoxazol
usual
effect
trimethoprim
mgkg
max
mg
plu
sulfamethoxazol
mgkg
max
mg
per
dose
given
everi
h
day
tetracyclin
chloramphenicol
aminoglycosid
strain
aeromona
resist
penicillin
includ
ampicillin
plesiomona
p
shigelloid
like
aeromona
commonli
found
environ
especi
bodi
water
includ
water
home
aquarium
unlik
aeromona
howev
plesiomona
report
occur
epidem
contamin
water
often
found
caus
plesiomona
also
known
spread
improperli
cook
seafood
pathogenesi
diseas
caus
p
shigelloid
well
understood
cytotoxin
found
strain
other
invas
mechan
also
suspect
coliti
symptom
addit
smallvolum
stool
leukocyt
possibl
blood
patient
may
also
experi
sever
abdomin
pain
fever
seen
approxim
onethird
patient
one
group
adult
patient
symptom
persist
longer
week
longer
week
diagnosi
p
shigelloid
made
stool
cultur
although
ill
usual
selflimit
treatment
antimicrobi
agent
shown
decreas
durat
symptom
trimethoprimsulfamethoxazol
aminoglycosid
suggest
appropri
choic
control
trial
antimicrobi
treatment
gastroenter
caus
organ
mycobacterium
avium
mycobacterium
intracellular
known
collect
mycobacterium
aviumintracellular
mycobacterium
avium
complex
mac
acidfast
bacilli
recogn
primarili
role
case
atyp
tuberculosi
organ
recogn
caus
agent
diarrheal
symptom
well
review
pediatr
case
atyp
mycobacteri
infect
lincoln
gilbert
describ
two
immunocompet
patient
whose
clinic
find
includ
diarrhea
colon
ulcer
even
greater
signific
sporad
case
mac
infect
immunocompet
host
occurr
among
immunocompromis
patient
patient
acquir
immunodefici
syndrom
mac
among
commonli
isol
agent
caus
system
bacteri
infect
patient
may
also
chronic
diarrhea
abdomin
pain
mac
also
note
caus
diarrhea
patient
undergo
bone
marrow
transplant
patient
cystic
fibrosi
mac
organ
may
cultur
gastric
duoden
aspir
obtain
endoscop
stool
bone
marrow
blood
endoscop
examin
patient
mac
may
reveal
find
similar
seen
whippl
diseas
minut
superfici
ulcer
small
bowel
treatment
mac
infect
convent
antituberculosi
agent
usual
unsuccess
erad
organ
allevi
symptom
bacteroid
fragili
anaerob
organ
commonli
isol
normal
stool
flora
howev
investig
identifi
toxinproduc
variant
enteropathogen
enterotoxigen
organ
isol
healthi
person
diarrhea
epidemiolog
associ
diarrhea
shown
enterotoxigen
b
fragili
sever
studi
other
addit
investig
requir
fulfil
koch
postul
organ
intestin
spirochetosi
colon
larg
bowel
brachyspira
aalborgi
relat
spirochet
recent
implic
caus
diarrhea
studi
shown
associ
organ
bloodi
diarrhea
although
asymptomat
colon
also
report
potenti
organ
caus
diarrhea
requir
evalu
organ
associ
diarrhea
sporad
case
least
one
hospit
outbreak
although
causal
relat
hafnia
alvei
diarrhea
clearli
establish
subset
organ
may
enteropathogen
organ
isol
patient
diarrhea
typic
demonstr
attach
effac
lesion
seen
epec
wherea
nonpathogen
isol
show
characterist
invas
ill
caus
listeria
well
known
outbreak
listeria
gastroenter
fever
without
invas
diseas
report
person
consum
contamin
chocol
milk
import
l
monocytogen
outbreak
gastroenter
caus
contamin
food
yet
adequ
determin
despit
chapter
extens
catalog
bacteri
viral
infecti
agent
case
diarrhea
current
attribut
known
caus
undoubtedli
techniqu
identif
cultur
becom
sophist
caus
agent
identifi
percentag
diarrheal
ill
describ
idiopath
nonspecif
continu
declin
advanc
widespread
use
improv
oral
rehydr
solut
led
declin
morbid
mortal
associ
diarrhea
futur
advanc
prevent
measur
includ
vaccin
may
lead
reduct
incid
diarrheal
diseas
